Appointment of Secretarial auditor by Shareholders of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shareholders of Sandu Pharmaceuticals approved the appointment of M/s Swapnil J Dixit & Associates, a peer-reviewed firm of Company Secretaries based in Goa, as the Secretarial Auditor at the 40th Annual General Meeting held on September 30, 2025. The appointment is for a period of five consecutive years, from FY 2025-26 to FY 2029-30 (April 1, 2025 to March 31, 2030), based on the recommendation of the Audit Committee and Board of Directors. This is a reappointment of the same auditor whose previous five-year tenure ended on March 31, 2025. The auditor is not related to any of the company's directors.
This is a routine regulatory compliance disclosure with no material impact on the stock. Shareholders have formally approved the secretarial auditor required under the Companies Act and SEBI listing regulations.